In order to evaluate whether sphingolipids could differentiate the hepatic necroinflammation (G≥2) in the subgroup of CHC patients with normal ALT levels, we also performed a univariate and multivariate analysis (Table 3). The gene discussed is GPT; the disease is cryohydrocytosis.